United States Sterilization Equipment Market Overview, 2031

Key Insights

According to the research report, "USA Sterilization Equipment Market Outlook, 2031," published by Bonafide Research, the USA Sterilization Equipment Market was valued at more than 4.71 Billion in 2025.
The surge in hospital-acquired infections (HAIs) and strict regulatory guidelines across healthcare facilities have turned the U.S. sterilization equipment sector into a critical, high-demand market. One of the primary insights driving this landscape is the regulatory and operational pivot away from traditional, hazardous chemicals toward eco-friendly low-temperature technologies. For decades, ethylene oxide (EtO) was the industry benchmark, but intense scrutiny from environmental bodies like the EPA regarding emissions and toxicity has forced facilities to adopt alternatives. This shift has triggered massive breakthroughs in low-temperature vaporized hydrogen peroxide (VHP) systems, nitrogen dioxide sterilization, and supercritical carbon dioxide techniques.
Modern central sterile supply departments (CSSDs) are moving away from manual logging toward fully automated reprocessing workflows that provide real-time batch validation, predictive maintenance alerts, and cloud-based tracking. On the numerical front, hospital-acquired infections remain a primary catalyst: CDC data indicates that roughly 1 in 31 hospital patients in the U.S. has at least one healthcare-associated infection on any given day, creating nearly 687,000 cases annually in acute care facilities alone. Additionally, heat sterilization equipment primarily moist-heat steam autoclaves continues to lead product adoption, handling over 60% of all processing volumes in clinical environments due to its cost-efficiency and proven efficacy for non-sensitive surgical steel instruments.
Compact, benchtop, and rapid-cycle tabletop sterilizers are seeing massive uptake to service smaller facilities that operate on tight, fast patient turnaround schedules. However, this expansion faces real-world operational friction: compliance audits reveal that approximately 15% to 20% of facility processing delays stem from improper pre-cleaning and bio-burden removal prior to actual sterilization. This has spurred integrated reprocessing solutions that blend automated washer-disinfectors, ultrasonic baths, and biological indicators into single, synchronized unit workflows to guarantee compliance.

Market Outlook

The U.S. sterilization landscape is positioned for sustained structural expansion driven by the aging demographic and rising volume of elective surgeries. As millions of baby boomers age into requirements for orthopedic implants, cardiovascular interventions, and outpatient procedures, the sheer volume of reusable surgical tools needing rapid turnaround will continue to strain processing capacity. Additionally, contract sterilization outsourcing where manufacturers and healthcare networks offload large-scale processing to dedicated third-party facilities is emerging as a primary growth channel to bypass high capital expenditure and regulatory burdens associated with maintaining in-house industrial sterilizers.
To maintain regulatory alignment and foster technological deployment, key industry players work closely alongside prominent national trade and safety organizations. Crucial industry trade bodies like the Association for the Advancement of Medical Instrumentation (AAMI), the Association of periOperative Registered Nurses (AORN), and the Healthcare Sterile Processing Association (HSPA) set standard operating protocols across the nation. Driving the equipment sector forward are major market-leading companies such as STERIS plc, Getinge AB, 3M Company, Belimed AG (Metall Zug), Advanced Sterilization Products (ASP / Fortive Corporation), and Sotera Health (Sterigenics).

Market Dynamics

Driver: Surging demand for elective surgeries and outpatient care
The primary catalyst fueling the U.S. sterilization equipment market is the steep rise in surgical procedure volumes, particularly within ambulatory surgery centers (ASCs) and outpatient settings. As the U.S. population ages, the frequency of joint replacements, cardiovascular procedures, and minimally invasive surgeries is accelerating rapidly. This sustained procedural volume forces healthcare facilities to increase their daily throughput of reusable surgical instruments and diagnostic equipment, making high-efficiency, fast-cycle sterilization systems essential to prevent operational bottlenecks and manage infection control risks.
Challenge: Evolving environmental restrictions and compliance costs
The biggest obstacle facing the industry is navigating stringent environmental and occupational safety regulations, particularly regarding Ethylene Oxide (EtO). The U.S. Environmental Protection Agency (EPA) and OSHA have placed strict limits on EtO off-gassing and workplace exposure due to its carcinogenic risks. Retargeting facilities to install advanced emission scrubbers, continuous air monitoring systems, and upgraded ventilation requires immense capital expenditure.
Trend: Migration to low-temperature and eco-friendly technologies
A dominant trend across the U.S. landscape is the rapid adoption of low-temperature sterilization alternatives most notably Vaporized Hydrogen Peroxide (VHP), Nitrogen Dioxide (〖"NO" 〗_2), and Liquid Chemical Sterilants. Modern medical instruments increasingly feature heat-sensitive micro-electronics, complex fiber optics, and delicate polymer compositions that cannot survive classic steam autoclaves. Healthcare facilities are favoring low-temperature VHP processes because they leave zero toxic residues, offer quick turnaround times, and align with institutional sustainability initiatives by replacing hazardous gases.

Policies

FDA 510(k) Premarket Notification & Category Validation: The U.S. FDA regulates sterilization equipment as Class II medical devices. Manufacturers must prove substantial equivalence via 510(k) clearances and maintain a strict Sterility Assurance Level (SAL) of 〖10〗^(-6) (demonstrating less than a one-in-a-million chance of a surviving microorganism). FDA classifies technologies into Category A (established methods like steam, radiation, EtO, VHP) and Category B (newer technologies requiring extensive custom validation).
EPA National Emission Standards for Hazardous Air Pollutants (NESHAP): Governs commercial sterilization facilities utilizing Ethylene Oxide (EtO) gas. The EPA enforces strict rules regulating chamber exhaust vents, aeration rooms, and fugitive emissions, requiring facilities to install advanced pollution control devices (catalytic oxidizers, wet scrubbers) to cut atmospheric emissions.
OSHA Permissible Exposure Limits (PELs): The Occupational Safety and Health Administration enforces strict standards to protect healthcare and factory workers handling sterilizing agents. It mandates permissible exposure limits (e.g., an 8-hour time-weighted average of 1 ppm for Ethylene Oxide and 1 ppm for Hydrogen Peroxide) alongside required continuous workplace monitoring and personal protective equipment (PPE).
ANSI/AAMI ISO Standards Compliance: Sterilization equipment must meet technical performance standards set by the Association for the Advancement of Medical Instrumentation (AAMI) and the American National Standards Institute (ANSI). Key compliance standards include ANSI/AAMI ST79 (steam sterilization and sterility assurance in healthcare facilities) and ISO 11135 / ISO 22441 (validation and routine control standards for gas and vaporized sterilizers).

Segment Analysis

USA Sterilization Equipment By Offering
The U.S. equipment segment is evolving from standalone sterilizers toward integrated, digitally monitored sterilization systems. Hospitals and manufacturers increasingly value equipment that can automatically record cycle parameters, generate electronic traceability records, detect process deviations and integrate with quality-management systems. Steam autoclaves remain fundamental for heat-resistant instruments, while low-temperature systems address increasingly complex polymer-based and electronic medical devices. CDC guidance identifies steam as the preferred method for critical instruments that tolerate heat and moisture.
Services are becoming an important part of the U.S. sterilization ecosystem because sterilization is not simply an equipment-purchase activity. Customers require installation qualification, operational qualification, performance qualification, validation, preventive maintenance, calibration, cycle development and regulatory documentation. Contract sterilization is particularly important for medical-device companies that do not want to construct and operate dedicated sterilization infrastructure.
Consumables represent a recurring requirement because sterilization processes depend on items such as sterilization pouches, wraps, containers, chemical indicators, biological indicators, filters and sterilization chemicals. Unlike capital equipment, these products are repeatedly consumed as sterilization cycles are performed. An important U.S. characteristic is the increasing emphasis on sterility assurance rather than simply sterilizer operation. Accessories are increasingly designed around workflow optimization and process assurance. Examples include sterilization baskets, trays, instrument containers, loading systems, water-treatment components, drying systems, sensors, monitoring devices and data-recording interfaces.

USA Sterilization Equipment By Technology/Method
High-temperature sterilization remains the backbone of healthcare sterilization in the U.S., particularly through steam autoclaves. The major advantage is the combination of strong microbial lethality, relatively simple operating principles, low toxicity and established clinical acceptance. The technology is particularly suited to metal surgical instruments and other heat- and moisture-resistant products. CDC identifies saturated steam under pressure as the most widely used and dependable sterilization method. Common steam sterilization temperatures include 121°C and 132°C, depending on the sterilizer and load.
Low-temperature sterilization is one of the most strategically important areas of the U.S. market. It enables sterilization of temperature-sensitive and moisture-sensitive medical devices, including products containing polymers, electronics, adhesives and complex components. EtO remains particularly important because of its ability to penetrate packaging and complex device geometries.
Radiation sterilization is particularly valuable for pre-packaged, single-use medical devices because products can often be sterilized after packaging without exposing them to high temperatures or moisture. Gamma radiation, electron beam and increasingly other radiation approaches serve different throughput and penetration requirements. The U.S. FDA has highlighted radiation as a major sterilization modality for medical devices, while also supporting development of alternatives and improved sterilization processes
Filtration differs from thermal, chemical and radiation sterilization because it primarily removes microorganisms rather than killing them. It is especially important for liquid and gas streams that cannot tolerate heat or chemical sterilants. The technology has strong relevance in pharmaceutical and biotechnology manufacturing, where sterile filtration can be incorporated into aseptic processing. Membrane selection, pore characteristics, integrity testing and compatibility with the formulation become central purchasing considerations.

USA Sterilization Equipment By End-User
Hospitals and clinics represent a core demand center because sterilization is directly connected with surgical procedures, invasive care and infection prevention. Their purchasing decisions increasingly consider cycle time, instrument throughput, compatibility with complex devices, documentation, energy/water consumption and ease of integration into sterile-processing workflows. Large hospitals may operate multiple technologies simultaneously, while smaller hospitals, specialty clinics and ambulatory facilities tend to favor compact, rapid-cycle and easier-to-operate systems.
Medical-device manufacturers require sterilization not only for final product safety but also as part of the product-development, validation and regulatory approval pathway. Sterilization method selection must consider material compatibility, packaging, device geometry, residuals, product functionality and shelf life. EtO has a particularly important role in this segment because many medical devices contain polymers and other materials that cannot tolerate conventional high-temperature sterilization. The FDA states that EtO remains the most commonly used method for sterilizing medical devices in the United States.
Pharmaceutical and biotechnology companies have a different sterilization requirement from hospitals because the objective often involves maintaining product sterility, aseptic processing and contamination control throughout manufacturing. Filtration is particularly important for heat-sensitive pharmaceutical solutions, while autoclaves and depyrogenation systems are used for suitable equipment, components and containers. The market therefore emphasizes validated processes, microbial-control strategies, sterile filtration, environmental monitoring and highly documented quality systems.
Food and beverage companies use sterilization and microbial-control technologies primarily to improve product safety, shelf stability and process reliability. Their requirements differ considerably from healthcare because throughput, continuous processing, product characteristics and preservation of taste or nutritional quality can be critical. The opportunity is strongest where manufacturers require controlled microbial reduction for packaging, ingredients, equipment or specialized products. Radiation, thermal processing and filtration can each serve different applications depending on the product and process.
The others category includes research laboratories, veterinary facilities, dental practices, academic institutions, diagnostic laboratories and specialized manufacturing environments. This segment tends to favor smaller-footprint equipment, flexible cycle programming, simple validation and lower operating complexity. Dental and laboratory users, for example, can have requirements similar to hospitals but often operate with considerably smaller instrument volumes.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Sterilization Equipment Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Offering
• Equipment
• Services
• Consumables & Accessories

By Technology / Method
• High-Temperature / Heat Sterilization
• Low-Temperature Sterilization
• Radiation Sterilization
• Filtration Sterilization

By End User
• Hospitals & Clinics (CSSD)
• Medical Device Manufacturers
• Pharmaceutical & Biotech
• Food & Beverage
• Others (Veterinary, Cosmetics)